Impact of COVID-19 on oncology clinical trials

ABSTRACT

The COVID-19 pandemic is disrupting clinical research in much of the world. To understand how the crisis is affecting the management of ongoing oncology clinical trials and the planning of future trials, we used a combination of surveys and interviews of oncology clinical investigators globally and analyses of data from IQVIA and ClinicalTrials.gov on oncology clinical trials to investigate challenges, risks and contingencies. Here, we present data and insights from this investigation in the hope that they could be useful to those involved in oncology clinical trials.